ResoTher Pharma
Holte
About ResoTher Pharma
ResoTher Pharma is a privately held biotechnology company located in Copenhagen, Denmark. The company is focused on developing peptide-based drugs derived from the endogenous immunomodulator Annexin A1 as resolution therapy for diseases where neutrophil-driven inflammation plays a key pathological role. Their current focus is on cardiovascular disorders and inflammatory disorders with a large unmet medical need.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $5.1M
- Last round: Grant (Nov 2023)
- Website: resotherpharma.com
- Phone: + 45 41 88 95 70
Industries & Categories
Biotechnology, Health Care, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/resother-pharma-76951 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.